drugset / Trial / NCT01712360

Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis

NCT01712360

Phase 4 Completed 56 enrolled Merz North America, Inc.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study is being done to see how the body is affected when a study drug is applied to both feet if the subject has athlete's foot or to both feet and the groin area if the subject has both athlete's foot and jock itch. Safety of the drug and how well the drug works will also be measured.

Timeline

Start
2012-10
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Naftifine Other / unclassified Topical